Advisory: Alert on Impel NeuroPharma announcing August cross-border volumes withdrawn
Sept 3 (Reuters) - The alert on Impel Neuropharma Inc
IMPL.O announcing its August 2021 cross-border volume is wrong
and has been withdrawn. It was inadvertently issued from an
unrelated company's regulatory filing. Other alerts on the chain
were correct.
Impel Neuropharma on Friday announced FDA approval of its
nasal spray for treatment of migraine. For correct set of
alerts, click on urn:newsml:reuters.com:*:nL4N2Q52SW.
STORY_NUMBER: ASA02KVK
STORY_DATE: 03/09/2021
STORY_TIME: 12:50:16
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq